|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02279 YONGHE MEDICAL
Nominal 
0.750 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | -20.331% | -2.801% | 5.014% | 12.934% | 4.277% |
| ROAE (%) | -43.230% | -5.229% | 11.423% | 50.632% | 16.097% |
| Return on Capital Employed (%) | -31.736% | -3.531% | 4.882% | 14.996% | 5.477% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 56.108% | 61.763% | 72.858% | 74.567% | 72.610% |
| EBITDA Margin (%) | -11.079% | 4.463% | 21.077% | 25.965% | 18.599% |
| Pre-tax Profit Margin (%) | -32.928% | -7.748% | 9.696% | 14.095% | 5.841% |
| Net Profit Margin (%) | -30.744% | -6.077% | 5.542% | 9.970% | 2.909% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.120 X | 2.386 X | 2.370 X | 0.866 X | 0.636 X |
| Quick Ratio (X) | 1.014 X | 2.209 X | 2.298 X | 0.813 X | 0.584 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 61.455% | 45.901% | 46.915% | 74.532% | 74.322% |
| Total Debt / Total Assets (%) | 44.816% | 35.340% | 31.930% | 53.677% | 59.371% |
| Net Debt / Total Assets (%) | 20.140% | 16.056% | -17.024% | 35.309% | 49.728% |
| Total Debt / Shareholders' Funds (%) | 116.232% | 65.325% | 60.149% | 210.758% | 231.209% |
| Long Term Debt / Shareholders' Funds (%) | 81.978% | 53.305% | 44.885% | 168.173% | 171.952% |
| Net Debt / Shareholders' Funds (%) | 52.234% | 29.679% | -32.070% | 138.636% | 193.659% |
| Net Cash / (Debt) ($) | (492.338M) | (470.509M) | 544.661M | (562.944M) | (463.078M) |
| Net Cash / (Debt) per share ($) | (0.934) | (0.893) | 1.048 | -- | -- |
| Total Debt / Capital Employed (%) | 63.634% | 42.585% | 41.498% | 78.575% | 84.993% |
| Interest Coverage Ratio (X) | N/A | N/A | 5.048 X | 7.363 X | 3.676 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 38.390 Day | 47.711 Day | 24.846 Day | 18.169 Day | 15.640 Day |
| Receivables Turnover (Day) | 1.779 Day | 2.636 Day | 1.993 Day | 1.803 Day | 2.335 Day |
| Payables Turnover (Day) | 12.670 Day | 10.338 Day | 6.794 Day | 7.488 Day | 5.830 Day |
| Remarks: | Real time quote last updated: 25/11/2024 09:33 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -138,572,000 |
| %Change | -38.737% |
| EPS / (LPS) | RMB -0.280 |
| NBV Per Share (¥) | RMB 1.526 |